Acquired Resistance to Targeted Therapies against Oncogene-Driven Non-Small Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications

In the emerging era of targeted therapy for advanced stage non-small cell lung cancer (NSCLC), it is becoming increasingly important to anticipate potential underlying driver oncogene alterations at the time of initial diagnosis and tumor tissue acquisition, so that patients can be selected in a tim...

Full description

Saved in:
Bibliographic Details
Published in:Clin Lung Cancer
Main Authors: Gandara, D.R., Li, T., Lara, P.N., Kelly, K., Riess, J.W., Redman, M. W., Mack, P.C.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4586161/
https://ncbi.nlm.nih.gov/pubmed/24176733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2013.10.001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items